×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 7 Track 3: Merge and Go! Learning Opportunities from the AbbVie/Allergan Experience
Session Chair(s)
Cindy Chiu
Senior Director, Regulatory Affairs Operations and Quality Management
Merck & Co., Inc., United States
The AbbVie/Allergan merger is one of the most recent for pharma. The intersection if Developmental and Regulatory Operation groups of two large organizations posed challenges for the systems, processes, and the people. We’ll present plans designed for success, assess the progress and outline some case studies that will be sure to initiate conversations!
Learning Objective : At the conclusion of this session, participants should be able to:
- Describe the technology challenges encountered on the M&A journey
- Identify the business processes impacted by the merger
- Discuss the impact on the personnel and mitigation strategies
Speaker(s)
Mergers and Acquisitions: The Penthouse View
Betsy Fallen, RN
BAFallen Consulting LLC, United States
Consultant
Maintaining Operational Momentum After A Merger
Representative Invited
Abbvie, United States
Have an account?